ArticleJournal of neuro-oncology2024

Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway.

Kaitao Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.